ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study
August 24, 2020 03:27 ET
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Aug. 24, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative...